HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoki Suichi Selected Research

Gerstmann Syndrome (Gerstmann's Syndrome)

5/2021Gerstmann's Syndrome in a Patient Double-positive for Antibodies against the N-methyl-D-aspartate Receptor and NH2-terminal of α-enolase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoki Suichi Research Topics

Disease

5POEMS Syndrome (Syndrome, POEMS)
06/2021 - 01/2019
2Polyneuropathies (Polyneuropathy)
01/2019 - 01/2019
2Guillain-Barre Syndrome
01/2018 - 11/2016
1Pathologic Constriction (Stenosis)
06/2021
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
05/2021
1Brain Diseases (Brain Disorder)
05/2021
1Encephalitis (Encephalitis, Rasmussen)
05/2021
1Gerstmann Syndrome (Gerstmann's Syndrome)
05/2021
1Andersen Syndrome
01/2019
1Neuralgia (Stump Neuralgia)
10/2018
1Pain (Aches)
10/2018
1Anaphylaxis (Anaphylactic Shock)
01/2018
1Abscess
01/2018

Drug/Important Bio-Agent (IBA)

4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 01/2019
4Proteins (Proteins, Gene)FDA Link
06/2021 - 01/2019
2eculizumabFDA Link
01/2018 - 11/2016
1AntibodiesIBA
05/2021
1Phosphopyruvate Hydratase (Enolase)IBA
05/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2020
1Thalidomide (Thalomid)FDA Link
05/2020
1Lenalidomide (CC 5013)FDA Link
05/2020
1Potassium Channels (Potassium Channel)IBA
01/2019
1Duloxetine Hydrochloride (Cymbalta)FDA Link
10/2018
1Inosine Monophosphate (IMP)IBA
10/2018
1Complement System Proteins (Complement)IBA
01/2018
1Monoclonal AntibodiesIBA
01/2018

Therapy/Procedure

1Therapeutics
10/2018
1Aftercare (After-Treatment)
10/2018
1Plasmapheresis
01/2018